In addition to a well-recognized UCP1-dependent thermogenic mechanism, there is a newly identified UCP1-independent thermogenic mechanism that could potentially offer a new target for the treatment of obesity and type 2 diabetes, especially targeting UCP1-negative adipocytes in the elderly and people with obesity (65–67). The gene discussed is UCP1; the disease is obesity due to melanocortin 4 receptor deficiency.